← Back to Clinical Trials
Recruiting NCT06850818

NCT06850818 Heidelberg Registry for Hip and Knee Joint Implants and Revisions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06850818
Status Recruiting
Phase
Sponsor University Hospital Heidelberg
Condition Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2007-01-01
Primary Completion 2035-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2007-01-01 with a primary completion date of 2035-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Endoprosthesis Registry Heidelberg (EPR-HD) is a clinical registry designed to systematically collect and analyze data from patients undergoing primary implantation or revision surgery of artificial hip and knee joints. The main objective of the registry is to evaluate long-term outcomes, complication rates, implant survival, and functional results associated with joint replacement procedures in patients with various hip and knee joint pathologies. By gathering comprehensive clinical data, EPR-HD aims to improve the understanding of patient outcomes after endoprosthetic procedures, identify potential factors influencing implant success, and support evidence-based improvements in surgical techniques and patient care. The registry includes adult patients treated at Heidelberg University Hospital, with data collected at multiple time points during routine clinical follow-up. This registry will contribute to the optimization of joint replacement strategies and promote high-quality patient care.

Eligibility Criteria

Inclusion Criteria: * All patients undergoing hip or knee arthroplasty at our institution * All patients undergoing revision surgery following hip oder knee arthroplasty Exclusion Criteria: * Lack of prospective consent for study participation * Lack of capacity to provide informed consent * Minor status (underage)

Contact & Investigator

Central Contact

Mustafa Hariri, MD

✉ mustafa.hariri@med.uni-heidelberg.de

📞 004962215635652

Frequently Asked Questions

Who can join the NCT06850818 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06850818 currently recruiting?

Yes, NCT06850818 is actively recruiting participants. Contact the research team at mustafa.hariri@med.uni-heidelberg.de for enrollment information.

Where is the NCT06850818 trial being conducted?

This trial is being conducted at Heidelberg, Germany.

Who is sponsoring the NCT06850818 clinical trial?

NCT06850818 is sponsored by University Hospital Heidelberg. The trial plans to enroll 10,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology